12 SSPs for HRT products extended as supply woes continue

Serious Shortage Protocols (SSPs) will remain in place on a raft of hormone replacement therapy (HRT) products until the end of October, as supply chain disruption continues to bite.

Some pharmacists have argued that SSPs do not address the root cause of drug shortages

Latest from News

More from Clinical